Navigation Links
Qforma Appoints Erin McLaughlin as Director, Field Operations
Date:10/29/2009

SANTA FE, N.M., Oct. 29 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointment of Erin McLaughlin to the position of director of field operations.

"Erin is a welcome addition to the Qforma family, and her appointment is the latest highlight in a year marked by company growth and important milestones," said Kelly D. Myers, CEO of Qforma. "Her combined background and expertise in analytics and healthcare will make her a perfect fit for our team and a valued asset to our customers."

As a director of field operations, McLaughlin will be responsible for consulting with the company's scientific team to design a customized project plan and specifications for each customer. She will work with customers throughout the solution implementation process to facilitate and track project progress, provide measurements of results during implementation and assist with final analysis of software deliverables.

McLaughlin comes to Qforma with more than 10 years of experience in the healthcare industry, in both an operational capacity and business development. She began her career with NDCHealth (now Wolters Kluwer Health), where she held positions in sales and management. Most recently, McLaughlin was an account manager with Surveillance Data Inc. (SDI), working with pharmaceutical and biotech company clients on the West Coast.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in solutions for the pharmaceutical and biotech industries. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques. In May 2009, Qforma launched "Most Influential Doctors" (MID), a first-of-its-kind online database presented by USA TODAY that provides consumers with information about the top community medical leaders in virtually every metropolitan area in the U.S. The recently expanded database is available at www.influentialdoctors.usatoday.com.

Qforma is headquartered in Santa Fe, NM, with offices in Princeton, NJ. More information is located at http://www.Qforma.com.

    Media Contacts:
    Lisa Haley, Qforma
    (505) 603-7596
    lhaley@qforma.com

    Jeff Hoyak, MCS Healthcare Public Relations
    (800) 477-9626, ext. 312
    jeffh@mcspr.com

SOURCE Qforma


'/>"/>
SOURCE Qforma
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. VitaminSpice Appoints Dr. Richard F. Seelig as Director
2. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
3. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
4. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
5. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
6. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
9. CeQur SA Appoints Eric Milledge Chairman of the Board of Directors
10. US HIFU Appoints Arie Belldegrun, M.D. to Board of Directors
11. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. ... a federal institution supporting research in Germany ... and patient treatments at the University Clinic Heidelberg as ... The MRIdian Linac program will be headed by ... also heads radiation oncology at the German Cancer Research ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
(Date:1/19/2017)... , January 19, 2017 ... Option to Address Motor Symptoms and Motor Complications ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... , European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 2017 , ... International Protein, a company based out of Australia that focuses ... January ECRM trade show in Hilton Head, SC. , International Protein was founded ... a line of products that would elevate her fitness regime. At this ECRM trade ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... sugar-free alternative VW+ 002. The drinks have been produced in collaboration with Zlatan ... perform during your workout. , After a successful launch in Sweden last year, ...
(Date:1/20/2017)... ... 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went ... creation of published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age ... at 19 years of age, he joined the Navy and got married right out of ...
(Date:1/20/2017)... ... ... in Suffolk”: a story of love, secrets, and mystery. “Christmas in Suffolk” is ... works in a daycare and looks for inspiration in the local coffee shop as ... Seymour’s new book is an adventure of love and secrets. , After ...
(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children and adults ... and achievable answer. “The Land of More and More” is the creation of published ... Indiana where he works with the children’s ministry department. , Michael says that ...
Breaking Medicine News(10 mins):